{"title":"内镜封闭治疗对食管癌相关瘘患者预后的影响:回顾性分析。","authors":"Qijie Dai, Xian Zhao, Weipeng Lu, Yitian Wang, Jiepeng Cen, Heqing Tao, Liang Peng","doi":"10.1159/000547231","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Esophageal cancer-associated fistula is strongly linked to elevated mortality. This study aims to investigate the impact of endoscopic closure on outcomes in patients with esophageal cancer-related fistula.</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical data of patients with esophageal cancer-related fistula. These patients were categorized into endoscopic closure group and conservative treatment group. The Clinical Pulmonary Infection Score (CPIS) gap, duration of hospitalization, ICU admission rates, in-hospital mortality rates, and hospitalization costs were compared between endoscopic group and conservative group. Additionally, factors associated with post-fistula survival and healing were assessed.</p><p><strong>Results: </strong>Univariate and multivariate COX regression analyses revealed that endoscopic closure could significantly improve short-term pulmonary infections based on CPIS gap (3 versus 2; P=0.004) but did not influence survival or fistula healing outcomes, and the hospitalization costs were elevated ($6653 versus $3350; P=0.005). Subgroup analysis focusing on esophagotracheal fistulas was also consistent with these results. Protective factors associated with improved survival prognosis included higher albumin levels (HR=0.928, 95%CI: 0.875-0.984, P=0.012), absence of bloodstream infections (positive blood culture (HR=23.055, 95%CI: 5.193-102.357, P<0.001)), non-T4 stage (T4 stage (HR=1.792, 95%CI: 1.052-3.052, P=0.032)) and no distant metastasis (distant metastasis (HR=2.122, 95%CI: 1.127-3.996, P=0.020)). Cervical esophageal fistula (upper (HR=0.154, 95% CI: 0.041-0.570, P=0.005); middle (HR=0.128, 95% CI: 0.027-0.609, P=0.010); lower (HR=0.218, 95% CI: 0.052-0.902, P=0.036)) was significantly associated with improved fistula healing outcomes, while a history of radiotherapy (HR=0.265, 95% CI: 0.089-0.788, P=0.017) was a risk factor for esophageal fistula healing.</p><p><strong>Conclusion: </strong>Our study indicates that multiple factors are significantly associated with the prognosis of patients with esophageal fistula. Endoscopic closure treatment effectively manages short-term infections but it associates with higher hospitalization costs and doesn't significantly enhance long-term healing or survival prognosis.</p>","PeriodicalId":11315,"journal":{"name":"Digestion","volume":" ","pages":"1-17"},"PeriodicalIF":3.0000,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The impact of endoscopic closure treatment on outcomes in patients with esophageal cancer-associated fistula: A retrospective analysis.\",\"authors\":\"Qijie Dai, Xian Zhao, Weipeng Lu, Yitian Wang, Jiepeng Cen, Heqing Tao, Liang Peng\",\"doi\":\"10.1159/000547231\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Esophageal cancer-associated fistula is strongly linked to elevated mortality. This study aims to investigate the impact of endoscopic closure on outcomes in patients with esophageal cancer-related fistula.</p><p><strong>Methods: </strong>We retrospectively analyzed the clinical data of patients with esophageal cancer-related fistula. These patients were categorized into endoscopic closure group and conservative treatment group. The Clinical Pulmonary Infection Score (CPIS) gap, duration of hospitalization, ICU admission rates, in-hospital mortality rates, and hospitalization costs were compared between endoscopic group and conservative group. Additionally, factors associated with post-fistula survival and healing were assessed.</p><p><strong>Results: </strong>Univariate and multivariate COX regression analyses revealed that endoscopic closure could significantly improve short-term pulmonary infections based on CPIS gap (3 versus 2; P=0.004) but did not influence survival or fistula healing outcomes, and the hospitalization costs were elevated ($6653 versus $3350; P=0.005). Subgroup analysis focusing on esophagotracheal fistulas was also consistent with these results. Protective factors associated with improved survival prognosis included higher albumin levels (HR=0.928, 95%CI: 0.875-0.984, P=0.012), absence of bloodstream infections (positive blood culture (HR=23.055, 95%CI: 5.193-102.357, P<0.001)), non-T4 stage (T4 stage (HR=1.792, 95%CI: 1.052-3.052, P=0.032)) and no distant metastasis (distant metastasis (HR=2.122, 95%CI: 1.127-3.996, P=0.020)). Cervical esophageal fistula (upper (HR=0.154, 95% CI: 0.041-0.570, P=0.005); middle (HR=0.128, 95% CI: 0.027-0.609, P=0.010); lower (HR=0.218, 95% CI: 0.052-0.902, P=0.036)) was significantly associated with improved fistula healing outcomes, while a history of radiotherapy (HR=0.265, 95% CI: 0.089-0.788, P=0.017) was a risk factor for esophageal fistula healing.</p><p><strong>Conclusion: </strong>Our study indicates that multiple factors are significantly associated with the prognosis of patients with esophageal fistula. Endoscopic closure treatment effectively manages short-term infections but it associates with higher hospitalization costs and doesn't significantly enhance long-term healing or survival prognosis.</p>\",\"PeriodicalId\":11315,\"journal\":{\"name\":\"Digestion\",\"volume\":\" \",\"pages\":\"1-17\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-07-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Digestion\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000547231\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digestion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000547231","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
The impact of endoscopic closure treatment on outcomes in patients with esophageal cancer-associated fistula: A retrospective analysis.
Introduction: Esophageal cancer-associated fistula is strongly linked to elevated mortality. This study aims to investigate the impact of endoscopic closure on outcomes in patients with esophageal cancer-related fistula.
Methods: We retrospectively analyzed the clinical data of patients with esophageal cancer-related fistula. These patients were categorized into endoscopic closure group and conservative treatment group. The Clinical Pulmonary Infection Score (CPIS) gap, duration of hospitalization, ICU admission rates, in-hospital mortality rates, and hospitalization costs were compared between endoscopic group and conservative group. Additionally, factors associated with post-fistula survival and healing were assessed.
Results: Univariate and multivariate COX regression analyses revealed that endoscopic closure could significantly improve short-term pulmonary infections based on CPIS gap (3 versus 2; P=0.004) but did not influence survival or fistula healing outcomes, and the hospitalization costs were elevated ($6653 versus $3350; P=0.005). Subgroup analysis focusing on esophagotracheal fistulas was also consistent with these results. Protective factors associated with improved survival prognosis included higher albumin levels (HR=0.928, 95%CI: 0.875-0.984, P=0.012), absence of bloodstream infections (positive blood culture (HR=23.055, 95%CI: 5.193-102.357, P<0.001)), non-T4 stage (T4 stage (HR=1.792, 95%CI: 1.052-3.052, P=0.032)) and no distant metastasis (distant metastasis (HR=2.122, 95%CI: 1.127-3.996, P=0.020)). Cervical esophageal fistula (upper (HR=0.154, 95% CI: 0.041-0.570, P=0.005); middle (HR=0.128, 95% CI: 0.027-0.609, P=0.010); lower (HR=0.218, 95% CI: 0.052-0.902, P=0.036)) was significantly associated with improved fistula healing outcomes, while a history of radiotherapy (HR=0.265, 95% CI: 0.089-0.788, P=0.017) was a risk factor for esophageal fistula healing.
Conclusion: Our study indicates that multiple factors are significantly associated with the prognosis of patients with esophageal fistula. Endoscopic closure treatment effectively manages short-term infections but it associates with higher hospitalization costs and doesn't significantly enhance long-term healing or survival prognosis.
期刊介绍:
''Digestion'' concentrates on clinical research reports: in addition to editorials and reviews, the journal features sections on Stomach/Esophagus, Bowel, Neuro-Gastroenterology, Liver/Bile, Pancreas, Metabolism/Nutrition and Gastrointestinal Oncology. Papers cover physiology in humans, metabolic studies and clinical work on the etiology, diagnosis, and therapy of human diseases. It is thus especially cut out for gastroenterologists employed in hospitals and outpatient units. Moreover, the journal''s coverage of studies on the metabolism and effects of therapeutic drugs carries considerable value for clinicians and investigators beyond the immediate field of gastroenterology.